Health
Ava Announces Launch of First Clinical Trial Evaluating Effectiveness of Its Fertility Tracking Sensor Bracelet in Real-time, Pre-Symptomatic Detection of COVID-19 – PRNewswire
/PRNewswire/ — Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind……
ZURICH, March 23, 2021 /PRNewswire/ — Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind to test whether a wearable device can detect a COVID-19 infection in real-time and alert people to get tested or self-isolate prior to showing symptoms.
While other studies to date (including the COVI-GAPP study Ava announced in April 2020
) have examined the feasibility of using machine learning and wearable devices…
-
Noosa News15 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
General12 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News21 hours agoQueensland Rail retires iconic electric train fleet after more than four decades
-
Business17 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth